Bird & Bird loses experienced IP litigator

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Bird & Bird loses experienced IP litigator

Veteran IP lawyer Wolfgang von Meibom has joined German prosecution and litigation boutique Vossius & Partner


Wolfgang Von Meibom

Von Meibom (right) joins from Bird & Bird, where he chaired the firm’s German operation and co-headed its international IP group. The experienced IP litigator also lectures on IP law. He has a professorship at the People’s University in Beijing and teaches at Munich Intellectual Property Law Center.

His move comes in the same month that four senior lawyers quit Bird & Bird in Sweden to launch their own firm, focusing on technology start-ups.

Von Meibom has authored a number of articles for Managing IP, with topics ranging from the use of expert witnesses, to litigating in Germany.

more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article